[ad_1]
Bangladesh will soon be involved in the production of vaccines by a foreign company. This process advances. Secretary of the Ministry of Health and Family Welfare. Abdul Mannan confirmed this information to Kaler Kantha on Tuesday night. However, it did not disclose the company name or ticker.
Secretary Abdul Mannan said: “The Oxford vaccine is now awaiting approval. Only then will we succeed. You have completed all the necessary preparations. However, now we want to present the country’s pharmaceutical industry to the world from the point of view of vaccination capacity. This capacity exists in our country. We have some world-class institutions in our country. Although the vaccine that is being produced now is not the vaccine of any company in our country. In our country the vaccine of a foreign company will be produced.
Meanwhile, the scope of vaccination is increasing in the country. Pfizer is currently being vaccinated. Another discussed modern ticker is likely to be approved tomorrow. The US Food and Drug Administration (FDA) has an advisory council meeting scheduled to decide. If approved, both Pfizer and modern vaccines will be introduced in different countries. Modern has announced that it is preparing for the launch of Modern Ticker in the United States starting on December 21.
Various sources in Bangladesh and India are looking at the possibility of the Oxford vaccine being approved in India at any time. According to them, the supply process will start in India and Bangladesh in a couple of days after the approval of the Oxford vaccine in India. Since the vaccine is being developed in India by the Serum Institute, the vaccine will be available in India within a day or two after approval. However, it will take longer to get it to Bangladesh and complete some process and get it to the implementation stage.
On the other hand, although everyone knows about the temperature crisis, there are still doubts about the lack of interest of the government in purchasing Pfizer and Modern vaccines in the country. Several vaccine experts told Kaler Kanth that it is wrong to be left alone at Oxford or Covacs. With this, it is important to take steps to collect modern vaccines and Pfizer, albeit in small quantities. Otherwise, there will be a kind of negative perception in people. Modern, Pfizer or multiple vaccines of this type should have been provided ahead of time, albeit through the private sector.
One scientist made it clear that while modern vaccines or Pfizer are difficult to provide to everyone in the country, it is not impossible for a small number of wealthy people to do so. Even IEDCR, ICDDRB or some other large pharmaceutical companies and laboratories in the country now have arrangements to store the vaccine. If necessary, it can be increased further. This will reduce pressure on at least one community and indirectly benefit others.
[ad_2]
